Ingvild K Høgestøl1,2, Monica Chahal-Kummen3, Inger Eribe3, Cathrine Brunborg4, Audun Stubhaug5,6, Stephen Hewitt3,5, Jon Kristinsson3, Tom Mala3,7. 1. Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway. i.k.hogestol@medisin.uio.no. 2. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. i.k.hogestol@medisin.uio.no. 3. Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway. 4. Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway. 5. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 6. Department of Pain Management and Research, Oslo University Hospital, Oslo, Norway. 7. Department of Gastrointestinal Surgery and Paediatric Surgery, Oslo University Hospital, Oslo, Norway.
Abstract
INTRODUCTION: Roux-en-Y gastric bypass (RYGB) is widely performed as treatment of morbid obesity. Long-term weight loss, effects on co-morbidities, and quality of life after RYGB have been well addressed. Other long-term outcomes are less elucidated. The aim of this study was to evaluate the prevalence, symptom characteristics, and possible predictors of chronic abdominal pain and gastrointestinal symptoms during consultations 5 years after RYGB. METHODS: A 5-year follow-up study of patients operated with RYGB 2008-2009 was performed. The patients completed questionnaires regarding chronic abdominal pain, the Gastrointestinal Symptom Rating Scale (GSRS), the ROME III questionnaire, the Hospital Anxiety and Depression Scale, Pain Catastrophing Scale (PCS), the Brief Pain Inventory, and SF-36. Uni- and multivariable logistic regression analyses of characteristics associated with chronic abdominal pain were performed. RESULTS: A total of 165/234 (71%) patients met to the follow-up, 160 of these accepted study inclusion. The mean follow-up was 64 (SD 4.2) months. The mean age was 42.5 (SD 8.7) years and 59% were females. The mean total weight loss was 23.9% (SD 11.2). Chronic abdominal pain was reported by 33.8%. Female gender, average strength of bodily pain, and the PCS sum score were associated with chronic abdominal pain. Symptoms of indigestion and irritable bowel syndrome were reported by 48.8% and 29.1%, respectively. Chronic abdominal pain was associated with reduced health related quality of life. CONCLUSION: A substantial proportion of patients experienced chronic abdominal pain and symptoms 5 years after RYGB. Abdominal pain should be addressed at follow-up consultations after RYGB.
INTRODUCTION: Roux-en-Y gastric bypass (RYGB) is widely performed as treatment of morbid obesity. Long-term weight loss, effects on co-morbidities, and quality of life after RYGB have been well addressed. Other long-term outcomes are less elucidated. The aim of this study was to evaluate the prevalence, symptom characteristics, and possible predictors of chronic abdominal pain and gastrointestinal symptoms during consultations 5 years after RYGB. METHODS: A 5-year follow-up study of patients operated with RYGB 2008-2009 was performed. The patients completed questionnaires regarding chronic abdominal pain, the Gastrointestinal Symptom Rating Scale (GSRS), the ROME III questionnaire, the Hospital Anxiety and Depression Scale, Pain Catastrophing Scale (PCS), the Brief Pain Inventory, and SF-36. Uni- and multivariable logistic regression analyses of characteristics associated with chronic abdominal pain were performed. RESULTS: A total of 165/234 (71%) patients met to the follow-up, 160 of these accepted study inclusion. The mean follow-up was 64 (SD 4.2) months. The mean age was 42.5 (SD 8.7) years and 59% were females. The mean total weight loss was 23.9% (SD 11.2). Chronic abdominal pain was reported by 33.8%. Female gender, average strength of bodily pain, and the PCS sum score were associated with chronic abdominal pain. Symptoms of indigestion and irritable bowel syndrome were reported by 48.8% and 29.1%, respectively. Chronic abdominal pain was associated with reduced health related quality of life. CONCLUSION: A substantial proportion of patients experienced chronic abdominal pain and symptoms 5 years after RYGB. Abdominal pain should be addressed at follow-up consultations after RYGB.
Authors: Ted D Adams; Lance E Davidson; Sheldon E Litwin; Ronette L Kolotkin; Michael J LaMonte; Robert C Pendleton; Michael B Strong; Russell Vinik; Nathan A Wanner; Paul N Hopkins; Richard E Gress; James M Walker; Tom V Cloward; R Tom Nuttall; Ahmad Hammoud; Jessica L J Greenwood; Ross D Crosby; Rodrick McKinlay; Steven C Simper; Sherman C Smith; Steven C Hunt Journal: JAMA Date: 2012-09-19 Impact factor: 56.272
Authors: Maurice Theunissen; Madelon L Peters; Julie Bruce; Hans-Fritz Gramke; Marco A Marcus Journal: Clin J Pain Date: 2012 Nov-Dec Impact factor: 3.442
Authors: Pål Klepstad; Jon Håvard Loge; Petter C Borchgrevink; Tito R Mendoza; Charles S Cleeland; Stein Kaasa Journal: J Pain Symptom Manage Date: 2002-11 Impact factor: 3.612
Authors: Hira Aftab; Hilde Risstad; Torgeir T Søvik; Tomm Bernklev; Stephen Hewitt; Jon A Kristinsson; Tom Mala Journal: Surg Obes Relat Dis Date: 2013-05-25 Impact factor: 4.734
Authors: Saskia L Boerboom; Ann de Haes; Lianne Vd Wetering; Edo O Aarts; Ignace M C Janssen; Jose W Geurts; Ed T Kamphuis Journal: Obes Surg Date: 2018-10 Impact factor: 4.129
Authors: Lindel C Dewberry; Jane C Khoury; Shelley Ehrlich; Todd M Jenkins; Andrew J Beamish; Heidi J Kalkwarf; Stavra A Xanthakos; Thomas Inge Journal: J Pediatr Surg Date: 2019-02-28 Impact factor: 2.545
Authors: Nathalia Ramori Farinha Wagner; Marilia Rizzon Zaparolli Ramos; Ligia de Oliveira Carlos; Magda Rosa Ramos da Cruz; Cesar Augusto Taconeli; Alcides José Branco Filho; Luis Sergio Nassif; Maria Eliana Madalozzo Schieferdecker; Antônio Carlos Ligocki Campos Journal: Obes Surg Date: 2020-08-11 Impact factor: 4.129
Authors: Karl P Rheinwalt; Andreas Plamper; Marcia V Rückbeil; Andreas Kroh; Ulf P Neumann; Tom F Ulmer Journal: Obes Surg Date: 2020-04 Impact factor: 4.129